Fair Value Measurements (Tables)

6 Months Ended

Jun. 30, 2026

The table below presents activity within Level 3 of the fair value hierarchy, our liabilities carried at fair value relating to the medac settlement, for the six months ended June 30, 2026:


	Level 3
(In thousands)	Contingent liabilities
Balance at January 1, 2026	$	864
Change due to liability payment	(235)
Liability fair value adjustment	—
Total change in foreign exchange	(19)
Balance at June 30, 2026	$	610

Schedule of Financial Assets and Liabilities Measured at Fair Value

The following tables present information about the Company’s financial assets and liabilities that have been measured at fair value as of June 30, 2026 and December 31, 2025 and indicate the fair value hierarchy of the valuation inputs utilized to determine such fair value.


	June 30, 2026
(In thousands)	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Assets:
Money market funds	$	2	$	—	$	—	$	2
U.S. government agency bonds	—		48,381		—		48,381
Total Assets	$	2	$	48,381	$	—	$	48,383

Liabilities:
Contingent Liability	$	—	$	—	$	610	$	610
Total Liabilities	$	—	$	—	$	610	$	610


	December 31, 2025
(In thousands)	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
Assets:
Money market funds	$	2	$	—	$	—	$	2
U.S. government agency bonds	—		47,582		—		47,582
Total Assets	$	2	$	47,582	$	—	$	47,584

Liabilities:
Contingent Liability	$	—	$	—	$	864	$	864
Total Liabilities	$	—	$	—	$	864	$	864